digestive enzymes and semaglutide While on GLP-1: Safety Evidence Oral Semaglutide, the First Ingestible

Current evidence suggests there may be a link between GLP-1 medications and hair loss, particularly with semaglutide (Wegovy) and tirzepatide (Mounjaro), but researchers have not proven that the medication itself directly causes hair loss

This is particularly true with the GLP-1 receptor agonist drugs

But while GLP-1s are commonly used by perimenopausal women, this population has been largely ignored in studies of the drugs' risks and benefits

This is a process where your body becomes more efficient at the exercise youre doing and can impact your ability to break through a plateau

The mechanism appears to involve stimulation of the median nerve, which affects nausea-related brain signals